Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call

29.07.25 17:28 Uhr

Werte in diesem Artikel

MISSISSAUGA, ON, July 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the second quarter of 2025 after the market close on Thursday, August 7, 2025. The Company will also hold a conference call on Friday, August 8, 2025 at 8:30am ET to discuss the results and corporate developments.

CONFERENCE CALL DETAILS

DATE:

                  Friday, August 8, 2025

TIME:

                  8:30 a.m. ET

DIAL-IN NUMBER:

                  416-945-7677 or 888-699-1199

REPLAY:

                  289-819-1450 or 888-660-6345 Code: 36094#


                  Expires: August 15, 2025

WEBCAST:

                  https://app.webinar.net/2vQrZ2AYmV5

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Ausgewählte Hebelprodukte auf Cipher Pharmaceuticals

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cipher Pharmaceuticals

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Cipher Pharmaceuticals IncShs

Wer­bung